Ultragenyx Pharmaceutical Inc. RARE on Thursday reported mixed fourth-quarter earnings and initiated a strategic restructuring plan. “The year ahead marks an important turning point for the company, ...

WWD has learned the brand laid off about 30 percent of its workforce.

Shares of Ultragenyx Pharmaceutical were lower after the company said it would lay off 10% of its workforce in a corporate restructuring. Shares were down 8.7% at $21.47 midday Friday. The stock has ...

Dow Inc. declared a quarterly dividend of 35 cents per share on Friday, extending a dividend streak that dates back more than a century.

Q4 2025 earnings call recap: restructuring wins, debt reduction, and 2026 EPS/sales guidance amid weak housing.